Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing | News
Search Refinements

Manufacturing News

View news from other Pharmaceutical sectors:
1-15 of 2253 results
Catalent to acquire Indiana-based CDMO Cook Pharmica for $950m
By PBR Staff Writer
Catalent has agreed to acquire Indiana-based contract development and manufacturing organization (CDMO) Cook Pharmica for $950m to consolidate its position in the bio-pharma sector.
Production & Manufacturing > Manufacturing > News
CHMP recommends GSK, Innoviva’s single inhaler triple therapy for COPD
By PBR Staff Writer
GlaxoSmithKline (GSK) and Innoviva announced that a committee of the European Medicines Agency (EMA) has adopted positive opinion for fluticasone furoate/ umeclidinium/vilanterol (FF/UMEC/VI) in treating chronic obstructive pulmonary disease (COPD) in adults.
Production & Manufacturing > Manufacturing > News
Eli Lilly to cut 3,500 jobs globally
By PBR Staff Writer
Eli Lilly plans to cut its overall workforce by 3,500 and trim its global operations to improve its cost structure for facilitating development of new medicines.
Production & Manufacturing > Manufacturing > News
Bioverativ, Bicycle Therapeutics to develop therapies for hemophilia and sickle cell disease
Bioverativ and Bicycle Therapeutics have announced a research collaboration focused on the discovery, development and commercialization of innovative therapies for hemophilia and sickle cell disease.
Production & Manufacturing > Manufacturing > News
PATH boosts leadership in developing and introducing urgently needed vaccines
PATH has received a $120m grant from the Bill & Melinda Gates Foundation to further strengthen its PATH Center for Vaccine Innovation and Access (CVIA), which works across every stage of vaccine research, development, and introduction for diseases in low-resource settings.
Production & Manufacturing > Manufacturing > News
TiGenix obtains commercial production license for expanded manufacturing facility
TiGenix has obtained a license for the commercial production of expanded adipose-derived stem cells (eASCs) at its expanded manufacturing facility in Madrid.
Production & Manufacturing > Manufacturing > News
Therapure Biopharma to sell CDMO business to 3SBio
By PBR Staff Writer
Canada-based Therapure Biopharma has agreed to divest its contract development and manufacturing (CDMO) business to a joint venture between Chinese biotechnology company 3SBio and CPE Funds for $290m.
Production & Manufacturing > Manufacturing > News
AstraZeneca, Takeda to develop MEDI1341 for Parkinson’s disease
AstraZeneca and Takeda Pharmaceutical have entered into an agreement to jointly develop and commercialise MEDI1341, an alpha-synuclein antibody currently in development as a potential treatment for Parkinson’s disease (PD).
Production & Manufacturing > Manufacturing > News
Celgene exercises option to extend strategic collaboration scope and term with Forma Therapeutics
Forma Therapeutics and Celgene announced an innovative R&D partnership in 2014 to pursue ground-breaking medicines in oncology and other therapeutic areas.
Production & Manufacturing > Manufacturing > News
Genmab, Seattle Genetics to co-develop tisotumab vedotin for solid tumors
Genmab and Seattle Genetics announced that Seattle Genetics has exercised its option to co-develop tisotumab vedotin.
Production & Manufacturing > Manufacturing > News
Daiichi Sankyo, Boston Pharmaceuticals sign deal for selective RET inhibitor for solid tumors
Daiichi Sankyo and Boston Pharmaceuticals have entered into a worldwide licensing agreement for Daiichi Sankyo's novel RET inhibitor, DS-5010.
Production & Manufacturing > Manufacturing > News
Xoma announces license agreements for gevokizumab and its IL-1 beta intellectual property portfolio
Xoma has licensed the global commercial rights to gevokizumab, a novel anti-IL-1 beta allosteric monoclonal antibody, to Novartis.
Production & Manufacturing > Manufacturing > News
Gilead Sciences to buy Kite Pharma for $11.9bn
By PBR Staff Writer
Biopharmaceutical firm Gilead Sciences has agreed to acquire US-based Kite Pharma for around $11.9bn.
Production & Manufacturing > Manufacturing > News
CF PharmTech raises $65m to accelerate development of its inhalation products and manufacturing capacity
CF PharmTech announced that it has raised $65M in a Series D financing. Future Industry Investment Fund, a private equity fund managed by SDIC Fund Management Corporation Limited (SDIC Fund Management), led the financing along with other prestigious healthcare investment groups in China.
Production & Manufacturing > Manufacturing > News
Samsung Bioepis’ Humira biosimilar Imraldi approved in Europe
By EBR Staff Writer
Samsung Bioepis' Imraldi, the anti-TNF biosimilar of Humira (adalimumab), has been approved by the European Commission (EC) for all indications of the AbbVie monoclonal antibody.
Production & Manufacturing > Manufacturing > News
1-15 of 2253 results